Adagene Stock Quote Today


USD 1.13  0.05  4.63%   

Market Performance
0 of 100
Odds Of Distress
Less than 23
Adagene is trading at 1.13 as of the 9th of December 2022, a 4.63% increase since the beginning of the trading day. The stock's lowest day price was 1.09. Adagene has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Adagene are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of November 2022 and ending today, the 9th of December 2022. Click here to learn more.
Fiscal Year End
IPO Date
9th of February 2021
Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company was incorporated in 2011 and is headquartered in Suzhou, China. Adagene Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 43.42 M outstanding shares of which 111.4 K shares are presently shorted by private and institutional investors with about 1.05 trading days to cover. More on Adagene

Moving together with Adagene

+0.79BXRXBaudax BioInc Upward RallyPairCorr

Moving against Adagene

-0.79BMYBristol-Myers Squibb Sell-off TrendPairCorr
-0.76DRIDarden Restaurants Earnings Call This WeekPairCorr
-0.69JPMJPMorgan Chase Fiscal Year End 13th of January 2023 PairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Adagene Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Adagene's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Adagene or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Adagene generated a negative expected return over the last 90 days
Adagene may become a speculative penny stock
Adagene has high historical volatility and very poor performance
The company reported the previous year's revenue of 10.18 M. Net Loss for the year was (73.18 M) with profit before overhead, payroll, taxes, and interest of 10.18 M.
Adagene currently holds about 168.04 M in cash with (43.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from Oxford Biomedicas next CEO to start in March Kre Schultz ready to wrap up Teva tenure early - Endpoints News
Average Analyst Recommendation
Analysts covering Adagene report their recommendations after researching Adagene's financial statements, talking to executives and customers, or listening in on Adagene's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Adagene. The Adagene consensus assessment is calculated by taking the average forecast from all of the analysts covering Adagene.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Adagene's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Adagene (ADAG) is traded on NASDAQ Exchange in USA and employs 259 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 48.85 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Adagene's market, we take the total number of its shares issued and multiply it by Adagene's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Adagene conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 43.42 M outstanding shares of which 111.4 K shares are presently shorted by private and institutional investors with about 1.05 trading days to cover. Adagene currently holds about 168.04 M in cash with (43.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Adagene Probability Of Bankruptcy
Adagene retains a total of 43.42 Million outstanding shares. Adagene shows 10.69 percent if its outstanding shares held by insiders and 10.69 percent owned by other corporate entities . Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Adagene Ownership Details

Adagene Stock Price Odds Analysis

What are Adagene's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Adagene jumping above the current price in 90 days from now is about 60.38%. The Adagene probability density function shows the probability of Adagene stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Adagene has a beta of 0.8362. This suggests as returns on the market go up, Adagene average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Adagene will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Adagene is significantly underperforming NYSE Composite.
  Odds Below 1.13HorizonTargetOdds Above 1.13
39.52%90 days
Based on a normal probability distribution, the odds of Adagene to move above the current price in 90 days from now is about 60.38 (This Adagene probability density function shows the probability of Adagene Stock to fall within a particular range of prices over 90 days) .

Adagene Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Adagene market risk premium is the additional return an investor will receive from holding Adagene long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Adagene. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Adagene's alpha and beta are two of the key measurements used to evaluate Adagene's performance over the market, the standard measures of volatility play an important role as well.

Adagene Stock Against Markets

Picking the right benchmark for Adagene stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Adagene stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Adagene is critical whether you are bullish or bearish towards Adagene at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Adagene without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Optimizer Now


Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
All  Next Launch Module

Adagene Corporate Management

Elected by the shareholders, the Adagene's board of directors comprises two types of representatives: Adagene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Adagene. The board's role is to monitor Adagene's management team and ensure that shareholders' interests are well served. Adagene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Adagene's outside directors are responsible for providing unbiased perspectives on the board's policies.
Guizhong Liu - Head PharmacologyProfile
Xiaohong She - VP OperationsProfile
Ling Zhou - Head HRProfile
Man MBA - CFO DirectorProfile
Qinghai Zhao - Chief OfficerProfile
Fangyong Du - Chief OfficerProfile
Ami Knoefler - VP CommunicationsProfile

Invested in Adagene?

The danger of trading Adagene is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Adagene is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Adagene. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Adagene is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the Adagene information on this page should be used as a complementary analysis to other Adagene's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Adagene Stock analysis

When running Adagene price analysis, check to measure Adagene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adagene is operating at the current time. Most of Adagene's value examination focuses on studying past and present price action to predict the probability of Adagene's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Adagene's price. Additionally, you may evaluate how the addition of Adagene to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Valuation
Check real value of public entities based on technical and fundamental data
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Is Adagene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adagene. If investors know Adagene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adagene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
48.9 M
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Adagene is measured differently than its book value, which is the value of Adagene that is recorded on the company's balance sheet. Investors also form their own opinion of Adagene's value that differs from its market value or its book value, called intrinsic value, which is Adagene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adagene's market value can be influenced by many factors that don't directly affect Adagene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adagene's value and its price as these two are different measures arrived at by different means. Investors typically determine Adagene value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adagene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.